31 results
8-K
EX-99.1
VTRO
Vitro Biopharma, Inc.
22 Jan 24
Vitro Biopharma Announces New Chief Financial Officer
9:17pm
developmental delays including autistic features, language delays, intellectual disability, neuro-irritability and significant behavioral concerns. We currently
8-K
EX-10.2
VTRO
Vitro Biopharma, Inc.
22 Jan 24
Vitro Biopharma Announces New Chief Financial Officer
9:17pm
not experienced any illness, injury, or disability compensable or recoverable under the worker’s compensation laws of any state, and Haas agrees that he … will not file a worker’s compensation claim asserting the existence of any such illness, injury, or disability. Haas understands and agrees
10-12G/A
n082k auav
21 Dec 22
Registration of securities (amended)
4:50pm
10-12G/A
5imihbm3hufiesz
4 Nov 22
Registration of securities (amended)
3:29pm
S-1/A
amobx7gajlde
3 Nov 22
IPO registration (amended)
5:28pm
10-12G
EX-99.1
fcei6x966lgs220zin
9 Sep 22
Registration of securities
9:46pm
S-1
EX-10.4
ay22x1hz1 6wk0n
9 Sep 22
IPO registration
5:13pm
S-1
EX-10.19
b2btp0ai
9 Sep 22
IPO registration
5:13pm
S-1
bo7wym5iwz6rqtgir
9 Sep 22
IPO registration
5:13pm
S-1
EX-10.8
erqe 9vnrddin1l5
9 Sep 22
IPO registration
5:13pm
S-1
EX-10.18
8u1ir
9 Sep 22
IPO registration
5:13pm